Literature DB >> 15580449

[Barrett's esophagus].

W K H Kauer1, H J Stein, H J Dittler, J R Siewert.   

Abstract

INTRODUCTION: It is widely accepted that long segments of Barrett's esophagus are caused by end-stage gastroesophageal reflux disease (GERD), but little is known about the correlation of severity of GERD and extent of metaplasia.
METHODS: Twenty normal volunteers and 142 patients with different extent of intestinal metaplasia (39 with intestinal metaplasia limited to the esophagogastric junction, 48 with short segments of Barrett's esophagus, and 55 with long segments) underwent manometry and combined pH-bilirubin monitoring.
RESULTS: The extent of intestinal metaplasia correlated to the exposition of gastric and duodenal juice in the esophagus and inversely with a competent lower esophageal sphincter.
CONCLUSIONS: The extent of intestinal metaplasia is related to the severity of GERD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580449     DOI: 10.1007/s00104-004-0952-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  23 in total

1.  The lower end of the oesophagus.

Authors:  J HAYWARD
Journal:  Thorax       Date:  1961-03       Impact factor: 9.139

2.  Circadian esophageal motor function in patients with gastroesophageal reflux disease.

Authors:  H J Stein; E P Eypasch; T R DeMeester; T C Smyrk; S E Attwood
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

3.  Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux.

Authors:  S Oberg; M P Ritter; P F Crookes; M Fein; R J Mason; M Gadensytätter; C G Brenner; J H Peters; T R DeMeester
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.452

4.  Functional foregut abnormalities in Barrett's esophagus.

Authors:  H J Stein; S Hoeft; T R DeMeester
Journal:  J Thorac Cardiovasc Surg       Date:  1993-01       Impact factor: 5.209

5.  Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease.

Authors:  G M Campos; S R DeMeester; J H Peters; S Oberg; P F Crookes; J A Hagen; C G Bremner; L F Sillin; R J Mason; T R DeMeester
Journal:  Arch Surg       Date:  2001-11

6.  Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux.

Authors:  H J Stein; A P Barlow; T R DeMeester; R A Hinder
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

7.  Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease.

Authors:  S Oberg; J H Peters; T R DeMeester; P Chandrasoma; J A Hagen; A P Ireland; M P Ritter; R J Mason; P Crookes; C G Bremner
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

8.  The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure.

Authors:  S Oberg; T R DeMeester; J H Peters; J A Hagen; J J Nigro; S R DeMeester; J Theisen; G M Campos; P F Crookes
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

9.  Short-segment Barrett's esophagus: A prevalent complication of gastroesophageal reflux disease with malignant potential.

Authors:  G W Clark; A P Ireland; J H Peters; P Chandrasoma; T R DeMeester; C G Bremner
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

10.  Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.

Authors:  Benjamin Avidan; Amnon Sonnenberg; Thomas G Schnell; Gregorio Chejfec; Adrienne Metz; Stephen J Sontag
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.